Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2.
Xie Y, Yin W, Zhang Y, Shang W, Wang Z, Luan X, Tian G, Aisa HA, Xu Y, Xiao G, Li J, Jiang H, Zhang S, Zhang L, Xu HE, Shen J.
Xie Y, et al. Among authors: aisa ha.
Cell Res. 2021 Nov;31(11):1212-1214. doi: 10.1038/s41422-021-00570-1. Epub 2021 Sep 28.
Cell Res. 2021.
PMID: 34584244
Free PMC article.
No abstract available.